Status:
UNKNOWN
High Dose Chemotherapy and Autologous Transplant for Breast Cancer
Lead Sponsor:
Stanford University
Conditions:
Graft vs Host Disease
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
To determine survival outcomes for patients with chemosensitive brest cancer after treatment with high dose chemotherapy
Eligibility Criteria
Inclusion
- Stage II, III or IV breast cancer
- chemosensitive
- adequate organ function
Exclusion
- prior transplant,
- life threatening disease
- brain metastases
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
March 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00186641
End Date
March 1 2005
Last Update
July 11 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University Cancer Center
Stanford, California, United States, 94305